159 related articles for article (PubMed ID: 28630652)
1. Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease.
Himoto T; Fujita K; Nomura T; Tani J; Morishita A; Yoneyama H; Haba R; Masaki T
Diabetol Metab Syndr; 2017; 9():45. PubMed ID: 28630652
[TBL] [Abstract][Full Text] [Related]
2. Involvement of essential trace elements in the pathogenesis of hepatitis C virus‑related chronic liver disease and nonalcoholic steatohepatitis.
Himoto T; Fujita K; Mimura S; Tani J; Morishita A; Kubota S; Masaki T
Exp Ther Med; 2024 Jan; 27(1):19. PubMed ID: 38223320
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of insulin resistance and hepatic steatosis deriving from zinc deficiency in patients with HCV-related chronic liver disease.
Himoto T; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Haba R; Masugata H; Masaki T
Biol Trace Elem Res; 2015 Feb; 163(1-2):81-8. PubMed ID: 25413880
[TBL] [Abstract][Full Text] [Related]
4. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
[TBL] [Abstract][Full Text] [Related]
5. B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease.
Miyake T; Abe M; Tokumoto Y; Hirooka M; Furukawa S; Kumagi T; Hamada M; Kawasaki K; Tada F; Ueda T; Hiasa Y; Matsuura B; Onji M
Hepatol Int; 2013 Jun; 7(2):539-47. PubMed ID: 26201785
[TBL] [Abstract][Full Text] [Related]
6. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
7. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Chitturi S; Abeygunasekera S; Farrell GC; Holmes-Walker J; Hui JM; Fung C; Karim R; Lin R; Samarasinghe D; Liddle C; Weltman M; George J
Hepatology; 2002 Feb; 35(2):373-9. PubMed ID: 11826411
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
Sterling RK; Smith PG; Brunt EM
J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
[TBL] [Abstract][Full Text] [Related]
10. Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity.
Lazar MV; Eapen M; Nair HR; Siyad I; Gopalakrishna R
Indian J Gastroenterol; 2020 Feb; 39(1):42-49. PubMed ID: 32222944
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease.
Himoto T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Senda S; Haba R; Ueno M; Yamaoka G; Masaki T
Diabetol Metab Syndr; 2013 Sep; 5(1):51. PubMed ID: 24016701
[TBL] [Abstract][Full Text] [Related]
12. The pathological appearance of hyaline droplets in Kupffer cells is not specific to patients with autoimmune hepatitis.
Himoto T; Kadota K; Fujita K; Nomura T; Morishita A; Yoneyama H; Masaki T
Int J Clin Exp Pathol; 2017; 10(8):8703-8708. PubMed ID: 31966728
[TBL] [Abstract][Full Text] [Related]
13. The ratio of insulin-like growth factor-I/insulin-like growth factor-binding protein-3 in sera of patients with hepatitis C virus-related chronic liver disease as a predictive marker of insulin resistance.
Himoto T; Tani J; Miyoshi H; Yoneyama H; Mori H; Inukai M; Masugata H; Goda F; Senda S; Haba R; Masaki T
Nutr Res; 2013 Jan; 33(1):27-33. PubMed ID: 23351407
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
16. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
17. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
Barb D; Bril F; Kalavalapalli S; Cusi K
J Clin Endocrinol Metab; 2019 Aug; 104(8):3327-3336. PubMed ID: 30848827
[TBL] [Abstract][Full Text] [Related]
18. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Ballestri S; Nascimbeni F; Romagnoli D; Lonardo A
Hepatol Res; 2016 Oct; 46(11):1074-1087. PubMed ID: 26785389
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.
Kado A; Tsutsumi T; Yotsuyanagi H; Ikeuchi K; Okushin K; Moriya K; Koike K; Fujishiro M
J Gastroenterol; 2023 Dec; 58(12):1237-1251. PubMed ID: 37707595
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
Koike K
Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
